Through intentional design, renewable energy investments and a deep commitment to innovation and efficiency, we can redefine what responsible growth looks like. The post Growth Without Compromise: Building The Future of Medicines Sustainably appeared first on MedCity News.
A major Medicare Advantage company has paid the government more than $342 million to help settle allegations that it overcharged the federal healthcare program for years. Elevance Health, which covers about 2 million people on Medicare, sent the money to the Centers for Medicare & Medicaid Services via wire transfer on May 27, court records…
GSK paid $85 million up front for global rights to a small-interfering RNA therapy discovered and developed by startup Empirico. The pharmaceutical giant said this drug candidate could be used as a monotherapy and as part of drug combinations for treating COPD and other inflammatory respiratory diseases. The post GSK’s Respiratory Pipeline Adds an Early-Stage…
On the heels of a scuttled hospital merger between rivals in Terre Haute, Indiana, a state senator introduced a bill that would forbid similar mergers in the future. Last year, nonprofit Union Health tried to acquire the only other acute care hospital in Vigo County by leveraging a state law it helped create that allows…
[Sponsored] Mayo Clinic physicians developed a clinical decision support tool to standardize care and improve care quality across Mayo Clinic. AskMayoExpert is the evolution of that work. The post The Evolution of a Clinical Decision Support Network appeared first on MedCity News.
Cigna Healthcare has partnered with Headspace to offer over 7 million members access to Headspace’s digital mental health tools. The post Cigna Launches Mental Health Collaboration with Headspace appeared first on MedCity News.
When we pause and view success through the eyes of a parent or caregiver, one goal stands above all others: we want our loved ones healthy and home as quickly and safely as possible. The post There’s No Place Like Home — Improving Outcomes and Recovery Time for Pediatric Cardiac Care appeared first on MedCity…
A new poll finds U.S. voters far more concerned about healthcare costs than any other major issue
Keros Therapeutics will present Phase 2 data for the drug, elritercept, at the annual meeting of the American Society of Hematology. Meanwhile, the Takeda deal enables Keros to focus on two wholly owned assets, one of which could compete with a Merck drug approved earlier this year. The post Takeda Pays $200M for Keros Therapeutics…
The One Big Beautiful Bill Act introduced a new $50 billion fund to offer rural hospitals a financial lifeline. One expert cautions that this effort will fail to address systemic challenges without transparency, clear metrics and long-term infrastructure investment strategies. The post Without Clear Strategy, CMS’ $50B Rural Hospital Fund Risks Falling Short appeared first…